Data Snapshot: Oct 05, 2026
$100K+

Sep-2026

Sales

Decline

Trend

6-Month

27

Product Count

SKUs

$33.86

Avg Price

-40.6%

YoY Sales Change

-8.3%

YoY Price Change

Kikoko is a pioneering cannabis brand under Stinson Brands, Inc. that focuses on the production of organic, precision-dosed wellness products, aiming to aid sleep improvement, anxiety reduction, pain relief, and even libido enhancement. Operating from the Bay Area, the brand stands out as a distinctively female-run enterprise that not only sells via dispensaries and delivery services but also holds informational, cannabis-oriented 'high tea' parties, featuring their signature low-dose THC and CBD teas.
Kikoko

Where to Buy

Kikoko is stocked at 183 licensed dispensaries across California, with the deepest coverage in Los Angeles, San Diego, Sacramento, Santa Rosa, and Vista. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.

https://headsetstorage.blob.core.windows.net/brand-stores/1865.json?v=20261004
Kikoko Sales

Market Insights Snapshot

Kikoko Historical Sales by Category

Kikoko’s category mix in September 2026 is concentrated in Capsules at 83.81% share with a year-over-year decline of 41.24% and a month-over-month slip of 2.64%, while Edible holds 12.08% share with a 37.97% YoY drop and a 20.99% MoM contraction, and Beverage accounts for 4.12% share with a 33.69% YoY decline and a 5.61% MoM decline. The brand’s average price decreased 8.35% YoY to $33.86, alongside an overall brand sales decline of 40.58% YoY and 53.45% versus 24 months, and within Capsules the brand sits at rank 6 in California; together, the heavier exposure to the steeply contracting Capsules segment and sharper Edible MoM pullback imply that mix, not just pricing, is driving the outsized sales contraction.

The consolidation around Capsules at 83.81% share combined with a rank of 6 in California suggests a defensible but narrow positioning, as the 41.24% YoY decline in Capsules and the 20.99% MoM slide in Edible reduce diversification options, while Beverage’s 4.12% share and 5.61% MoM decline limit offset potential. The 8.35% YoY price reduction alongside a smaller MoM decline in Capsules than in Edible (2.64% vs. 20.99%) implies price moves are not sufficient to alter trajectory; the path forward is a deliberate reweighting toward categories with shallower declines and stabilizing price-pack architecture to mitigate further share erosion within the current rank band.

Sep-2026 Rank
Beverage
Capsules
Edible
15
6
42
Category
Share of Sales
Avg Item Price
YoY %
MoM %
Capsules
83.8%
$39.12
-41.2%
-2.6%
Edible
12.1%
$18.53
-38.0%
-21.0%
Beverage
4.1%
$25.85
-33.7%
-5.6%
Kikoko

Competitive Landscape

Kikoko ranks #6 in CA Capsules in September 2026, down 2 positions year over year from #4, and unchanged versus three months ago at #6, indicating a stall after peaking at #4 in December 2025; meanwhile, Emerald Bay Extracts climbed from #6 to #1 with 109.3% YoY sales growth, and Level slid from #1 to #4 alongside a 50.3% YoY sales decline, creating a spread where Breez holds #2 despite a 26.2% YoY drop and ABX / AbsoluteXtracts sits at #5 with a 32.7% YoY decline; this rank trajectory implies Kikoko is being bracketed by faster risers above and contracting peers nearby, so without a catalyst it risks being locked in the mid-tier rather than reattaining the #4 peak.

Kikoko market ranking for CA Capsules

Kikoko

Notable Products

The steepest decline in September 2026 came from Little Helpers - Buzz Mints 20-Pack (100mg), dropping 42.6% MoM and sliding to rank 8, while Little Helpers - THC/THCV 1:1 Boost Matcha Botanical Mints 20-Pack (50mg THC, 50mg THCV) fell 40.8% MoM to rank 7. In contrast, XTabs - Hybrid High Dose Tablets 20-Pack (1000mg) rose 30.4% MoM to hold rank 1, and XTabs - Indica High Dose Tablets 20-Pack (1000mg) gained 4.8% MoM at rank 2. With three of the top five and four of the top ten coming from Capsules, the mix points to a pivot toward high-dose tablet formats and away from Edible mints, concentrating share at the top while trimming breadth in confections.

Product
Category
May-2026
Jun-2026
Jul-2026
Aug-2026
Sep-2026
MoM %
XTabs - Hybrid High Dose Tablets 20-Pack (1000mg)
Capsules
3
3
2
3
1
+30.4%
XTabs - Indica High Dose Tablets 20-Pack (1000mg)
Capsules
2
2
3
2
2
+4.8%
XTabs - Sativa High Dose Tablets 20-Pack (1000mg)
Capsules
1
1
1
1
3
-31.0%
Little Helpers - CBN/THC/Melatonin 3:2 Sleep Mints 20-Pack (60mg CBN, 40mg THC, 20mg Melatonin)
Edible
4
4
4
4
4
-8.7%
XTabs - THC/CBN/CBD Sleep Tablets 20-Pack (200mg CBD, 200mg CBN, 500mg THC)
Capsules
5
5
5
5
5
-6.4%
Little Helpers - CBD/THC 2:1 Calm Mints 20-Pack (100mg CBD, 50mg THC)
Edible
6
6
6
6
6
-9.8%
Little Helpers - THC/THCV 1:1 Boost Matcha Botanical Mints 20-Pack (50mg THC, 50mg THCV)
Edible
7
8
8
7
7
-40.8%
Little Helpers - Buzz Mints 20-Pack (100mg)
Edible
8
7
7
8
8
-42.6%
Sensuali Tea - Passion + Play Hibiscus Cardamom Rose Tea 7-Pack (49mg)
Beverage
>10
>10
>10
>10
9
—
XTabs - Hybrid Tablets 2-Pack (100mg)
Capsules
>10
>10
>10
>10
10
—
View product & sales data

Top Selling Cannabis Brands

Simple, transparent pricing that grows with you.
Research the top cannabis brands across markets in the US and Canada.

Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.

Header image
User rating
start Today
Stay ahead of the competition with real-time market data insights.

Discover How Your Brand Stacks Up in the Market